The government approves the purchase of Moderna vaccines

Lithuania will buy a 496,000 dose of the vaccine from these US biotech companies under a pre-agreement to coordinate purchases with the European Commission, waiving the right to buy an additional dose of the same amount. In total, the countries of the European Union will buy a total of 80 million. dose of this vaccine.

The Ministry of Health believes that the specific component of the vaccine is the information RNA (mRNA), that is, it is developed on the same platform as other vaccines purchased from Pfizer and BioNTech and CureVac Lithuania.

According to SAM, interim phase 3 clinical trials of the vaccine show that Moderna’s vaccine is nearly 95% effective. Two doses of the vaccine will be needed for vaccination, and the second dose will be given four weeks later.

The vaccine is known to have no serious side effects, but it is a new type of vaccine that has so far not been used in medicine or veterinary medicine, and there is little data on its efficacy in the elderly. It is also observed that the possible long-term effects of mRNA on inflammatory and autoimmune processes are not yet known and, as with any other vaccine, its efficacy may be due to mutations in the new coronavirus.

This is Lithuania’s first vaccine agreement. The country has already decided to buy vaccines from five companies: AstraZeneca, Janssen Pharmaceutica NV, Sanofi and GSK, BioNTech and Pfizer and CureVac.

Enough vaccine is planned to be purchased to vaccinate 70% of the country’s population, but due to existing agreements and the desire to reduce risks, much more will be purchased than is needed by the general population. Unused vaccines will be available for sale or donation to third parties.

The European Medicines Agency said Tuesday that a decision on the use of the Moderna vaccine is due in mid-January, when a decision on the use of the product developed by BioNTech and Pfizer is expected by the end of December at the latest.

According to Acting Minister of Health Aurelijus Veryga, the European Medicines Agency is expected to issue a permit by the end of December.

Vaccination priorities have been developed

A.Veryga says that it is planned to vaccinate doctors first, but according to him, the preparation of the vaccination decision of the target and priority groups of the population is being completed.

It has been prepared for practice and should be posted tomorrow for harmonization. The groups have already been named there: what is the priority, how much vaccine is administered, who and how many are vaccinated, said A. Veryga.

Acting Minister of Finance Vilius Apoka stressed that it has not yet grown if the need for the purchase of vaccines will amount to several or several tens of millions of euros, so it is expected that the purchase of vaccines will be made by the State.

Reproduction of BNS news in the media and on websites without the consent of the UAB “BNS” is prohibited.

Rayti komentar